3-Azabicyclo[3.1.0]hexane, 1-[4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-, hydrochloride (1:1), (1R,5R)-
3-Azabicyclo[3.1.0]hexane, 1-[4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-, hydrochloride (1:1), (1R,5R)-
FOB
MOQ:
1 g
Shipping:
Express Delivery
Product details
Essential details
MOQ:1 g
Lead time:4 weeks
Shipping:Express Delivery
Product Introduction
A pharmaceutical intermediate specifically developed for the synthesis of active pharmaceutical ingredients (APIs) and key drug intermediates. It offers high purity and structural stability, catering to R&D and industrial applications in medicinal and organic chemistry.